Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
09/15/2017 09/18/2017 09/19/2017 09/20/2017 09/21/2017 Date
2450(c) 2406.5(c) 2416.5(c) 2404.6(c) 2442 Last
20 875 6 290 6 671 6 948 8 637 Volume
+1.91% -1.78% +0.42% -0.49% +1.56% Change
More quotes
Financials ( INR)
Sales 2018 32 501 M
EBIT 2018 4 836 M
Net income 2018 3 787 M
Finance 2018 6 371 M
Yield 2018 2,00%
Sales 2019 36 326 M
EBIT 2019 5 873 M
Net income 2019 4 498 M
Finance 2019 7 826 M
Yield 2019 2,11%
P/E ratio 2018 53,90
P/E ratio 2019 45,14
EV / Sales2018 6,05x
EV / Sales2019 5,37x
Capitalization 203 B
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
10/25Earnings Release
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
09/08 GlaxoSmithKline Exercises Option For Adaptimmune Oncology Programme
08/30 GLAXO SMITH KLINE : GlaxoSmithKline's board ratifies dividends by 5% from delaye..
08/18 GLAXOSMITHKLINE : taps Baltimores Insilico for AI-based drug discovery
08/06 DSIJ TOP 1000 COMPANIES - 2 : Glaxosmithkline pharmaceuticals limited
07/28 JOHNSON & JOHNSON : Drugs giant GSK set to sell rare diseases business to step u..
07/26 GLAXOSMITHKLINE : Glaxo reports 2Q loss
07/26 GLAXOSMITHKLINE PHARMACEUTICALS : Q1 NET PROFIT DIVES 63% TO Rs26 CRORE
07/26 GLAXOSMITHKLINE PHARMACEUTICALS : Q1 performance temporarily impacted by GST tra..
07/20 GLAXOSMITHKLINE : will cut 320 jobs, none in Philadelphia or the U.S.
07/19 GLAXOSMITHKLINE PHARMACEUTICALS : Glaxo to axe 320 UK jobs in manufacturing shak..
More news
Sector news : Pharmaceuticals - NEC
11:16aDJPFIZER : Files Antitrust Lawsuit Against J&J -- WSJ
09/20DJPFIZER : Alleges J&J Thwarted Competition to Remicade, in Legal Test of Biotech-..
09/20 Pfizer files suit against J&J over Remicade contracts
09/20DJPFIZER : Files Antitrust Lawsuit Alleging J&J Thwarted Use of Biosimilar Rival t..
09/20DJSANOFI : Alnylam Report Positive Patisiran Phase III Trial, First-Ever for RNAi ..
More sector news : Pharmaceuticals - NEC
Latest Tweets
06/02GlaxoSmithKline Pharmaceuticals : ARMMAN wins share of GSK and Save the Child.. 
04/23Nigerian researchers win GSK’s Open Lab Research Grants: GlaxoSmithKline Phar.. 
2016#Indian #stocks: #Market: Glaxosmithkline Pharmaceuticals : Apr 2016 growth p.. 
2015#Indian #stocks: #Merger #Acquisition: Glaxosmithkline Pharmaceuticals : spar.. 
2015#Indian #stocks: #Market: Glaxosmithkline Pharmaceuticals : Sep 2015 growth p.. 
More tweets
Qtime:6
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Technical analysis trends GLAXOSMITHKLINE PHARMACEUT
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Average target price 2 574  INR
Spread / Average Target 7,4%
EPS Revisions
Managers
NameTitle
Annaswamy Vaidheesh Managing Director & Executive Director
Deepak Shantilal Parekh Non-Executive Chairman
Andrew Aristidou Chief Financial Officer & Executive Director
Raju Krishnaswamy Executive Director & Technical Director
Vrishali Desai Vice President-Medical & Clinical Research
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED-10.26%3 148
JOHNSON & JOHNSON16.70%362 930
NOVARTIS11.20%225 262
ROCHE HOLDING LTD.4.56%220 102
PFIZER9.45%211 109
MERCK AND COMPANY12.38%179 869